FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Metformin Hydrochloride Extended Release 750 Recall

Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repac…

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Nov 4, 2020
Recall ID
D-0050-2021
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Metformin Hydrochloride Extended Release 750 starting Oct 11, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0050-2021 on Nov 4, 2020. Reason: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer). Status: Terminated.

Why it was recalled

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Product description

Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA NDC 70518-2480-00

Lot numbers, UPCs & expiration codes

Lot Numbers: J0423350-121219 exp. date 12/31/2020 J0434828-020320 exp. date 02/28/2021 J0442511-031220 exp. date 03/31/2021 J0448429-040920 exp. date 04/30/2021 J0472499-081020, J0472532-081020 exp. date 08/31/2021

Where it was sold

Product was distributed to one customer in PA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0050-2021
Classification
Class II
Status
Terminated
Recall initiated
Oct 11, 2020
FDA report date
Nov 4, 2020
Quantity
79/30 count blister cards
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0050-2021, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
86624
Address
625 Kolter Dr Ste 4
Code information
Lot Numbers: J0423350-121219 exp. date 12/31/2020 J0434828-020320 exp. date 02/28/2021 J0442511-031220 exp. date 03/31/2021 J0448429-040920 exp. date 04/30/2021 J0472499-081020, J0472532-081020 exp. date 08/31/2021
Postal code
15701-3571
Report date
Nov 4, 2020
Product type
Drugs
Recall number
D-0050-2021
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
79/30 count blister cards
Termination date
Feb 24, 2021
Reason for recall
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA NDC 70518-2480-00
Distribution pattern
Product was distributed to one customer in PA.
Recall initiation date
Oct 11, 2020
Initial firm notification
Letter
Center classification date
Oct 26, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0050-2021, published Nov 4, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls